Osteoarthritis and Cartilage
Volume 20, Issue 2 , Pages 79-86 , February 2012

Relationship between insulin-like growth factor-1 and radiographic disease in patients with primary osteoarthritis: a systematic review

  • K.M.J.A. Claessen

      Affiliations

    • Department of Endocrinology & Metabolic Diseases, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    • Corresponding Author InformationAddress correspondence and reprint requests to: K.M.J.A. Claessen, Department of Endocrinology and Metabolic Diseases C4-R, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. Tel: 31-71-5266896; Fax: 31-71-5248136.
    • K.M.J.A.C. and S.R.R. contributed equally to this work.
  • ,
  • S.R. Ramautar

      Affiliations

    • Department of Endocrinology & Metabolic Diseases, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    • K.M.J.A.C. and S.R.R. contributed equally to this work.
  • ,
  • A.M. Pereira

      Affiliations

    • Department of Endocrinology & Metabolic Diseases, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • J.W.A. Smit

      Affiliations

    • Department of Endocrinology & Metabolic Diseases, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • N.R. Biermasz

      Affiliations

    • Department of Endocrinology & Metabolic Diseases, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • M. Kloppenburg

      Affiliations

    • Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands

Received 25 July 2011 ,Accepted 23 November 2011.

References 

  1. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helminck CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;133(8):635–646
  2. Peyron JG. Osteoarthritis. The epidemiologic viewpoint. Clin Orthop. 1986;213:13–19
  3. Spector TD, Cicuttini F, Baker J, Loughlin J, Hart DJ. Genetic influences on osteoarthritis in women: a twins study. BMJ. 1996;312:940–944
  4. Kellgren JH, Lawrence S, Bier F. Genetic factors in generalized osteoarthrosis. Ann Rheum Dis. 1963;22:237–253
  5. Hart DJ, Spector TD. The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford study. J Rheumatol. 1993;20(2):331–335
  6. George E, Sharif M, Dieppe P. Editorials, insulin-like growth factor 1 and biochemical markers of osteoarthritis. Br J Rheumatol. 1993;32:265–268
  7. LeRoith moderator . Insulin-like growth factors in health and disease. Ann Intern Med. 1992;116:854–862
  8. Copeland KC, Colletti RB, Devlin JT, McAuliffe TL. The relationship between insulin-like growth factor-I, adiposity, and aging. Metabolism. 1990 Jun;39(6):584–587
  9. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res. 2003;13:113–170
  10. Guenther HL, Guenther HE, Frosch ER, Flisch H. Effect of insulin-like growth factor on collagen and glycosaminoglycan synthesis by rabbit chondrocytes in culture. Experientia. 1982;38:979–981
  11. McQuillan DJ, Handley CJ, Campbell MA, Bolis S, Milway VE, Herington AC. Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-1 in cultured bovine articular cartilage. Biochem J. 1986;240:423–430
  12. Vetter U, Zapf J, Heit W, Helbing G, Heinze E, Froesch ER, et al. Human fetal and adult chrondrocytes: effect of insulin like growth factors I and II, insulin, and growth hormone on clonal growth. J Clin Invest. 1986;77:1903–1908
  13. Luyten FP, Hascall VC, Nissley SP, Morales TI, Reddi AH. Insulin-like growth factors maintain steady state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem Biophys. 1988;267:416–425
  14. Makower AM, Wroblewski J, Pawlowski A. Effects of IGF-I, ECF, and FGF on proteoglycans synthesized by fractionated chondrocytes of rat rib growth plate. Exp Cell Res. 1988;179:498–506
  15. Sandell LJ, Dudek E. IGF-I stimulates type II collagen gene expression in cultured chondrocytes. Orthop Trans. 1988;13:300
  16. Osborne KD, Trippel SB, Mankin HJ. Growth factor stimulation of adult articular cartilage. J Orthop Res. 1989;7:35–42
  17. Trippel SB, Corvol MT, Dumontier MF, Rappaport R, Hung HH, Mankin HJ. Effect of somatomedin-C/insulin-like growth factor I and growth hormone on cultured growth plate and articular chondrocytes. Pediatr Res. 1989;25:76–82
  18. Barone-Varelas J, Schnitzer TJ, Meng Q, Otten L, Thonar E. Age related differences in the metabolism of proteoglycans in bovine articular cartilage explants maintained in the presence of insulin-like growth factor-1. Connect Tissue Res. 1991;26:101–120
  19. Morales TI. Polypeptide regulators of matrix homeostasis in articular cartilage. In:  Kuettner K,  Schleyerbach R,  Peyron JG,  Hascall VC editor. Articular Cartilage and Osteoarthritis. New York: Raven Press; 1992;
  20. Schoenle E, Zapf J, Humbel RE, Froesch ER. Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature. 1982;96:252–253
  21. Tyler J. Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem J. 1989;260:543–548
  22. Fosang AJ, Typler JA, Hardingham TE. Effect of IL-1 and IGF-1 on the release of proteoglycan components and hyaluronan from pig articular cartilage in explant culture. Matrix. 1991;11:17–24
  23. Barkan AL. Acromegalic arthropathy. Pituitary. 2001;4:263–264
  24. Layton MW, Fudman EJ, Barkan A, Braunstein EM, Fox IH. Acromegalic arthropathy. Characteristics and response to therapy. Arthritis Rheum. 1998;31:1022–1027
  25. Biermasz NR, Wassenaar MJ, Van der Klaauw AA, Pereira AM, Smit JW, Roelfsema F, et al. Pretreatment insulin-like growth factor-I concentrations predict radiographic osteoarthritis in acromegalic patients with long-term cured disease. J Clin Endocrinol Metab. 2009;94:2374–2379
  26. Meulenbelt I, Bijkerk C, Miedema HS, Breedveld FC, Hofman A, Valkenburg HA, et al. A genetic association study of the IGF-1 gene and radiological osteoarthritis in a population-based cohort study (the Rotterdam Study). Ann Rheum Dis. 1998;57(6):371–374
  27. Urano T, Narusawa K, Shiraki M, Usui T, Sasaki N, Hosoi T, et al. Association of a single nucleotide polymorphism in the insulin-like growth-factor-1 receptor gene with spinal disc degeneration in postmenopausal Japanese women. Spine. 2008;33(11):1256–1261
  28. Zhai G, Rivadeneira F, Houwing-Duistermaat JJ, Meulenbelt I, Bijkerk C, Hofman A, et al. Insulin-like growth factor I gene promoter polymorphism, collagen type II alpha1 (COL2A1) gene, and the prevalence of radiographic osteoarthritis: the Rotterdam Study. Ann Rheum Dis. 2004;63(5):544–548
  29. Bijkerk C. Genetic epidemiology of OA. In: Association of the COL2A1 Gene with Radiological OA in a Population-based Cohort Study: The Rotterdam Study. Rotterdam: Erasmus University Rotterdam; 1999;p. 61–76
  30. McAlindon TE, Taele JD, Dieppe PA. Levels of insulin related growth factor 1 in osteoarthritis of the knee. Ann Rheum Dis. 1993;52(3):229–231
  31. Lloyd ME, Hart DJ, Nandra D, McAlindon TE, Wheeler M, Doyle DV, et al. Relation between insulin-like growth factor-I concentrations, bone density, and fractures in general population: the Chingford study. Ann Rheum Dis. 1996;55(12):870–874
  32. Hochberg MC, Lethbridge-Cejku M, Scott WW, Plato CC, Tobin JD. Decreased serum levels of insulin-like growth factor-1 in women with osteoarthritis of the hand: data from the Baltimore Longitudinal Study of Aging (BLSA). Osteoarthritis Cartilage. 1993;1(1):17
  33. Hochberg MC, Lethbridge-Cejku M, Scott WW, Reichle R, Plato CC, Tobin JD. Serum levels of insulin-like growth factor in subjects with osteoarthritis of the knee. Data from the Baltimore Longitudinal Study of Aging. Arthritis Rheum. 1994;37(8):1177–1180
  34. Lievense AM, Bierma-Zeinstra SMA, Verhagen AP, Verhaar JAN, Koes BW. Influence of work on the development of osteoarthritis of the hip: a systematic review. J Rheumatol. 2001;28:2520–2528
  35. Van Tulder M, Furlan A, Bombardier C, Bouter L. Updated method guidelines for systematic reviews in the Cochrane collaboration back review group. Spine. 2003;28:1290–1299
  36. Lievense AM, Bierma-Zeinstra SMA, Verhagen AP, van Baar ME, Verhaar JAN, Koes BW. Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology. 2002;41:1155–1162
  37. Fernihough JK, Billingham ME, Cqyfan-Hughes S, Holly JM. Local disruption of the insulin-like growth factor system in the arthritic joint. Arthritis Rheum. 1996;39(9):1556–1565
  38. Fraenkel L, Zhang Y, Trippel SB, McAlindon TE, LaValley MP, Assif A, et al. Longitudinal analysis of the relationship between serum insulin-like growth factor-I and radiographic knee osteoarthritis. Osteoarthritis Cartilage. 1998;6(5):362–367
  39. Denko CW, Boja B, Moskowitz RW. Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis – insulin, insulin-like growth factor-I, growth hormone. J Rheumatol. 1994;21(9):1725–1730
  40. Jubb RW. Cartilage growth factors and post-menopausal osteoarthritis. Br J Rheumatol. 1998;27(Suppl 1):21
  41. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes. 2001 Mar;50(3):637–642
  42. Ursavas A, Karadag M, Ilcol YO, Ercan I, Burgazlioglu B, Coskun F, et al. Low level of IGF-1 in obesity may be related to obstructive sleep apnea syndrome. Lung. 2007;185(5):309–314
  43. Miller KK, Biller BM, Lipman JG, Bradwin G, Rifai N, Klibanski A. Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J Clin Endocrinol Metab. 2005;90(2):768–774
  44. Schouten JS, Van den Ouweland FA, Valkenburg HA, Lamberts SW. Insulin-like growth factor-1: a prognostic factor of knee osteoarthritis. Br J Rheumatol. 1993;32(4):274–280
  45. Janssen JA, van der Lely AJ, Lamberts SW. Circulating free insulin-like growth-factor-I (IGF-I) levels should also be measured to estimate the IGF-I bioactivity. J Endocrinol Invest. 2003;26(6):588–594
  46. Brugts MP, Ranke MB, Hofland LJ, van der Wansem K, Weber K, Frystyk J, et al. Normal values of circulating insulin-like growth factor-1 bioactivity in the healthy population: comparison with five widely used IGF-1 immunoassays. J Clin Endocrinol Metab. 2008;93(7):2539–2545
  47. Varewijck AJ, Lamberts SWJ, Uitterlinden P, Hofland LJ. IGF-1 bioactivity more accurately reflects growth hormone deficiency than total IGF-1. Endocr Rev. 2001;32:OR 16–22

PII: S1063-4584(11)00324-4

doi: 10.1016/j.joca.2011.11.012

Osteoarthritis and Cartilage
Volume 20, Issue 2 , Pages 79-86 , February 2012